- Home
- Publications
- Publication Search
- Publication Details
Title
New treatments for levodopa-induced motor complications
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 30, Issue 11, Pages 1451-1460
Publisher
Wiley
Online
2015-08-21
DOI
10.1002/mds.26362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study
- (2015) Per Svenningsson et al. BRAIN
- A Long-Term Study of Istradefylline Safety and Efficacy in Patients With Parkinson Disease
- (2015) Tomoyoshi Kondo et al. CLINICAL NEUROPHARMACOLOGY
- Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease
- (2015) J. J. Ferreira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)
- (2015) Rajesh Pahwa et al. MOVEMENT DISORDERS
- Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease
- (2015) D. Calandrella et al. NEUROLOGY
- Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease
- (2014) S. Mazzucchi et al. ACTA NEUROLOGICA SCANDINAVICA
- Liquid Melevodopa Versus Standard Levodopa in Patients With Parkinson Disease and Small Intestinal Bacterial Overgrowth
- (2014) Alfonso Fasano et al. CLINICAL NEUROPHARMACOLOGY
- Therapeutic strategies to prevent and manage dyskinesias in Parkinson’s disease
- (2014) Manuela Pilleri et al. Expert Opinion On Drug Safety
- Safinamide for the treatment of Parkinson's disease
- (2014) Livia Dézsi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant
- (2014) Santiago Perez-Lloret et al. EXPERT OPINION ON PHARMACOTHERAPY
- Long-term levodopa/carbidopa intestinal gel in advanced Parkinson’s disease
- (2014) María T. Cáceres-Redondo et al. JOURNAL OF NEUROLOGY
- Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
- (2014) PD MED Collaborative Group LANCET
- Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
- (2014) Robert A Hauser et al. LANCET NEUROLOGY
- Novel formulations and modes of delivery of levodopa
- (2014) Werner Poewe et al. MOVEMENT DISORDERS
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results
- (2014) Hubert H. Fernandez et al. MOVEMENT DISORDERS
- EuroInf: AMulticenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
- (2014) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- Can a new trial end controversy over when to use levodopa?
- (2014) Olivier Rascol Nature Reviews Neurology
- Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients
- (2014) Fabrizio Stocchi et al. PARKINSONISM & RELATED DISORDERS
- Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease
- (2014) Christopher Kobylecki et al. PARKINSONISM & RELATED DISORDERS
- Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias
- (2014) Olivier Rascol et al. PARKINSONISM & RELATED DISORDERS
- Inhaled dry powder apomorphine (VR040) for ‘off ’ periods in Parkinson's disease: an in-clinic double-blind dose ranging study
- (2013) K. A. Grosset et al. ACTA NEUROLOGICA SCANDINAVICA
- Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?
- (2013) K. Ray Chaudhuri et al. JOURNAL OF NEURAL TRANSMISSION
- Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
- (2013) Robert A Hauser et al. LANCET NEUROLOGY
- Extended-release carbidopa-levodopa in Parkinson's disease
- (2013) Olivier Rascol LANCET NEUROLOGY
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease
- (2013) Peter A. LeWitt et al. MOVEMENT DISORDERS
- Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
- (2013) Rupam Borgohain et al. MOVEMENT DISORDERS
- Adenosine A2Areceptor antagonist istradefylline reduces daily OFF time in Parkinson's disease
- (2013) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study
- (2013) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Caffeine consumption and risk of dyskinesia in CALM-PD
- (2013) Anne-Marie A. Wills et al. MOVEMENT DISORDERS
- Wearing Off, Dyskinesia, and the Use of Continuous Drug Delivery in Parkinson's Disease
- (2013) Peter Jenner NEUROLOGIC CLINICS
- Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial
- (2013) F. Ory-Magne et al. NEUROLOGY
- Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia
- (2013) Erwan Bézard et al. NEUROSCIENCE RESEARCH
- Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys
- (2013) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- Actively Transported Levodopa Prodrug XP21279
- (2012) Peter A. LeWitt et al. CLINICAL NEUROPHARMACOLOGY
- Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over (“n-of-1”) exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients
- (2012) François Tison et al. PARKINSONISM & RELATED DISORDERS
- Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
- (2011) Robert A Hauser et al. LANCET NEUROLOGY
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinsonʼs Disease
- (2010) Angelo Antonini et al. CNS DRUGS
- Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-O-methyltransferase
- (2010) László E. Kiss et al. JOURNAL OF MEDICINAL CHEMISTRY
- Serotonin and Parkinson's disease: On movement, mood, and madness
- (2009) Susan H. Fox et al. MOVEMENT DISORDERS
- Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
- (2008) R. Katzenschlager et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started